MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling.

MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling.
复制标题

MicroRNA-125b 通过激活 RhoA 信号传导促进肝星状细胞激活和肝纤维化。

DOI:
10.1016/j.omtn.2018.04.016
复制
发表时间:
2018-09-07
期刊:
Molecular therapy. Nucleic acids
影响因子:
--
通讯作者:
Zhuang SM
Zhuang SM
中科院分区:
其他
文献类型:
--
作者:
You K;Li SY;Gong J;Fang JH;Zhang C;Zhang M;Yuan Y;Yang J;Zhuang SM

文献摘要

参考文献

被引文献

相似文献

miR-125 b在不同疾病中经常失调。肝星状细胞(hepatic stellate cells,HSC)的活化是肝纤维化发生过程中的一个重要环节。然而,miR-125 b在HSC活化和肝纤维化中的作用及其机制尚不清楚。在此,我们发现miR-125 b在体内肝纤维化过程中和体外培养激活后在HSC中上调,但在肝细胞中不上调。抑制miR-125 b可抑制培养活化的原代HSC中促纤维化基因的表达,并降低基础和转化生长因子β(TGF-β)诱导的α-平滑肌肌动蛋白(α-SMA)表达和永生化HSC细胞系的细胞收缩。相反,miR-125 b的异位表达促进α-SMA表达和HSC收缩。此外,体内拮抗miR-125 b显著减轻了CCl 4处理小鼠的肝纤维化。从机制上讲,在HSC中过表达miR-125 b通过直接靶向含有StAR相关脂质转移(START)结构域13(Stard 13)(一种RhoA特异性GTP酶激活蛋白)来增强RhoA活性,而敲低miR-125 b则废除RhoA激活。抑制RhoA或其下游分子Mrtf-A和Srf可减弱miR-125 b诱导的α-SMA表达和HSC收缩。因此,我们的研究结果确定了HSC中的miR-125 b-Stard 13-RhoA-α-SMA信号级联反应,并强调了其在肝纤维化中的重要性。
miR-125b is frequently dysregulated in different diseases. Activation of hepatic stellate cells (HSCs) is a critical event during liver fibrogenesis. However, the function and its underlying mechanism of miR-125b in HSC activation and liver fibrosis are still unknown. Here, we showed that miR-125b was upregulated in HSCs, but not in hepatocytes, during hepatic fibrogenesis in vivo and upon culture activation in vitro. Inhibition of miR-125b suppressed the expression of profibrogenic genes in culture-activated primary HSCs and reduced the basal and transforming growth factor β (TGF-β)-induced alpha-smooth muscle actin (α-SMA) expression and cell contraction of the immortalized HSC cell line. In contrast, ectopic expression of miR-125b promoted α-SMA expression and HSC contraction. Moreover, antagonizing miR-125b in vivo significantly alleviated liver fibrosis in CCl4-treated mice. Mechanistically, overexpression of miR-125b in HSCs enhanced RhoA activity by directly targeting StAR-related lipid transfer (START) domain containing 13 (Stard13), a RhoA-specific GTPase-activating protein, whereas knockdown of miR-125b abrogated RhoA activation. Furthermore, inhibition of RhoA or its downstream molecules, Mrtf-A and Srf, attenuated the miR-125b-induced α-SMA expression and HSC contraction. Therefore, our findings identify a miR-125b-Stard13-RhoA-α-SMA signaling cascade in HSCs and highlight its importance in hepatic fibrosis.
Toll样受体4的肝硬化预测单核苷酸多态性与肝星状细胞反应的功能联系。
DOI: 10.1002/hep.22697
发表时间: 2009-03
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Guo, Jinsheng;Loke, Johnny;Zheng, Feng;Hong, Feng;Yea, Steven;Fukata, Masayuki;Tarocchi, Mirko;Abar, Olivia T.;Huang, Hongjin;Sninsky, John J.;Friedman, Scott L.
通讯作者: Friedman, Scott L.
DOI: 10.1016/j.neuron.2010.01.005
发表时间: 2010-02-11
期刊: NEURON
影响因子: 16.2
作者:
Edbauer, Dieter;Neilson, Joel R.;Foster, Kelly A.;Wang, Chi-Fong;Seeburg, Daniel P.;Batterton, Matthew N.;Tada, Tomoko;Dolan, Bridget M.;Sharp, Phillip A.;Sheng, Morgan
通讯作者: Sheng, Morgan
DOI: 10.1016/j.jhep.2012.11.011
发表时间: 2013-03
影响因子: 25.7
作者:
Li, Jiang;Ghazwani, Mohammed;Zhang, Yifei;Lu, Jianqin;Li, Jilong;Fan, Jie;Gandhi, Chandrashekhar R.;Li, Song
通讯作者: Li, Song
DOI: 10.1177/1535370215605586
发表时间: 2016-02-01
影响因子: 3.2
作者:
Liu, Xiujuan;Hong, Quan;Xu, Lihong
通讯作者: Xu, Lihong
DOI: 10.1002/hep.23904
发表时间: 2010-11-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Liang, Linhui;Wong, Chun-Ming;He, Xianghuo
通讯作者: He, Xianghuo